Dextrose and Electrolyte No. 48 NDC 0338-0143

NDC codes

FDA NDC Directory

Product NDC (as listed)0338-0143Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00338-0143Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0338-0143-03	00338014303	500 mL in 1 BAG (0338-0143-03)Marketed from Feb 2, 1979

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextrose and Electrolyte No. 48
Generic name (nonproprietary): sodium lactate, potassium chloride, magnesium chloride, monobasic potassium phosphate, sodium chloride and dextrose monohydrate
Active ingredients: Dextrose monohydrate — 5 g/100mLSodium lactate — 260 mg/100mLPotassium chloride — 141 mg/100mLMagnesium chloride — 31 mg/100mLPotassium phosphate, Monobasic — 20 mg/100mLSodium chloride — 12 mg/100mL
Dosage form: Injection
Route: Intravenous
Labeler: Baxter Healthcare Company
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 017484
Marketing start: Feb 2, 1979
Listing expires: Dec 31, 2027
Other FDA classes: Acidifying Activity (Mechanism)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 0338-0143_548e1f27-50e8-4b74-b687-3f49bef9d895SPL ID 548e1f27-50e8-4b74-b687-3f49bef9d895SPL set ID b283a454-0c20-4fbf-92d3-dae1f3cd3cadRxCUI 807396UNII LX22YL083G, TU7HW0W0QT, 660YQ98I10, 02F3473H9O, 4J9FJ0HL51, 451W47IQ8X
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400338014303 followed by a unit qualifier and the quantity

Package 00338-0143-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 13, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE 5% Dextrose and Electrolyte No. 48 Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) is indicated as a source of water, electrolytes, and calories or as an alkalinizing agent.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)